“Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Efficacy and effects on quality of life” (2025) Research, Society and Development, 14(5), p. e4914548812. doi:10.33448/rsd-v14i5.48812.